Skip to content

Synthesis of the 3-(3,4,5-Trimethoxyphenyl)-pyrrolidine: A New Conformationally Constrained Mescaline Analogue

Ricardo de L. Barreto, Laura B. L. R. Nascimbem, Carlos Roque D. Correia

Synthetic Communications June 1, 2007 DOI: 10.1080/00397910701356504 via OpenAlex

Summary

AI-generated from the abstract

A new mescaline analogue, 3-(3,4,5-trimethoxyphenyl)-pyrrolidine, was synthesized in four steps from N-Cbz-3-pyrrolidine with a 46% overall yield. The key step was a Heck arylation of a non-activated olefin using a diazonium salt. The resulting hemiaminal intermediate was converted through dehydration with trifluoroacetic anhydride, then hydrogenation and hydrogenolysis, to yield the final compound as a hydrochloride salt. This conformationally constrained analogue may have activity towards 5-HT2 dopamine receptors.

Study at a glance

Characteristics Theoretical or philosophical paper Peer reviewed
Topics Mescaline
Keywords Pyrrolidine Hemiaminal Stereochemistry Trifluoroacetic anhydride
Citations 8
Key finding A concise total synthesis of a new conformationally constrained mescaline analogue was achieved in four steps with 46% overall yield.

Abstract

Abstract The total synthesis of the 3‐(3,4,5-trimethoxyphenyl)-pyrrolidine, a new and conformationally constrained mescaline analogue, was accomplished in a concise and efficient manner. The synthetic route encompassed only 4 steps from the starting N-Cbz-3-pyrrolidine, in 46% overall yield. The route features a highly effective Heck arylation of the non-activated olefin N-Cbz-3-pyrrolidine with the 3,4,5-trimethoxybenzene diazonium tetrafluoroborate. The hemiaminal (lactamol) Heck adduct was converted to the mescaline analogue in a sequence of reactions: (a) dehydration of the intermediate hemiaminal 3 with trifluoroacetic acid anhydride, (b) hydrogenation/hydrogenolysis of the endocyclic enecarbamate 6 with H2-Pd/C, and (c) formation of the rather stable mescaline analogue in the form of a hydrochloride salt. The target molecule constitutes a new mescaline analogue with potential activity towards 5‐HT2 dopamine receptors.

Explore topics

Comments

No comments yet.

Log in to comment